IRS Issues Final Rule Implementing Medical Device Excise Tax

The Internal Revenue Service released a

implementing a Patient Protection and Affordable Care Act provision that imposes on certain medical devices made after 2012 an excise tax equal to 2.3% of their sales price. In submitted on the proposed rule AHRMM, the American Hospital Association and others urged the IRS to explicitly prohibit device companies from passing the tax on to customers, and to clarify that hospitals and other healthcare providers who package and sterilize devices for use in surgery kits should not be treated as device manufacturers or importers under the rule. The final rule does not address AHRMM’s recommendation that manufacturers certify that the tax has not been passed on to customers, but provides that current rules apply in determining the sales price of items. Also, of importance, the final rule states that a kit produced by a hospital or medical institution for its own use would not be a taxable medical device.

Related Resources

Case Studies
WORK GROUP TITLE: UDI Capture Work Group CASE STUDY PARTICIPANTS:
Supply Chain Strategies & Solutions Article
The shift to bundled payments in health care continues to push the supply chain to a more central position in the overall operations and capa
Supply Chain Strategies & Solutions Article
The safe use of health technology—from infusion pumps to complex imaging systems—requires that healthcare facilities recognize the possibility of d
Supply Chain Strategies & Solutions Article
How often have you heard that supply chain is involved in patient care from the moment the patient walks in the door to discharge?
Supply Chain Strategies & Solutions Article
Download Article
White Papers
In 2014, AHRMM hosted the first Cost, Quality, and Outcomes (CQO) Summit to bring healthcare thought leaders together and discuss particular